Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC
Status:
Unknown status
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of hepatic arterial infusion
chemotherapy (HAIC) of oxaliplatin plus fluorouracil/leucovorin compared with HAIC of
oxaliplatin alone in patients with advanced hepatocellular carcinoma (HCC)
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Guangzhou No.12 People's Hospital Kaiping Central Hospital